|
Jul 29
|
AstraZeneca Profit, Revenue Lifted by Cancer Drugs
|
|
Jul 29
|
Pharma tariffs would be 'counterproductive,' industry rep. says
|
|
Jul 29
|
AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO
|
|
Jul 29
|
IonQ (IONQ) Names Quantum Pioneer Marco Pistoia As Senior Vice President
|
|
Jul 29
|
Why value investing has worked better outside the US
|
|
Jul 29
|
AstraZeneca (LSE:AZN) Reports Strong Revenue Growth and IMFINZI Gets Priority Review
|
|
Jul 29
|
AstraZeneca CFO talks tariffs & shifting focus to US market
|
|
Jul 29
|
FTSE 100 climbs as earnings cascade brings cheer
|
|
Jul 29
|
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
|
|
Jul 29
|
The Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo Nordisk
|
|
Jul 29
|
UK-listed AstraZeneca: ‘We are a very American company’
|
|
Jul 29
|
UnitedHealth's mixed Q2, Novo slashes forecast: What to know
|
|
Jul 29
|
Astrazeneca (AZN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Jul 29
|
AstraZeneca Stock Rises as US, Cancer Drugs Growth Lifts Q2 Results
|
|
Jul 29
|
AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform
|
|
Jul 29
|
Cancer drug demand drives higher sales for AstraZeneca
|
|
Jul 29
|
AstraZeneca results: H1 and Q2 2025
|
|
Jul 29
|
Health Care Roundup: Market Talk
|
|
Jul 29
|
AstraZeneca beats profit forecasts on strong sales and U.S. demand
|
|
Jul 29
|
Astrazeneca: Q2 Earnings Snapshot
|